INTRODUCTION
Studies by Wagner (1) on the quantitative estimation of glycogen in human blood disclosed the average glycogen content per 100 ml. to be 5.5 mg. In separated leukocytes an average of 2.54 micrograms of glycogen was found per 106 total leukocytes, or 4.23 micrograms per 106 granulocytic leukocytes. No detectable glycogen is present in human plasma or erythrocytes. It has been both denied (2) and claimed (3) on the basis of histochemical data that lymphocytes and platelets contain small amounts of glycogen. The work of Wagner (1, 4) , however, would indicate that the granulocytic leukocyte is probably the only significant representative of the white cells in the peripheral blood which contains glycogen. Studies on leukemic leukocytes (4) indicate that the blast cell contains no measurable amount of glycogen. Both histochemical studies (5) and the quantitative observations of Wagner (1, 4) suggest that glycogen first appears in the granulocytic leukocytes at the myelocytic stage and may increase with increasing cell maturity. Wagner (4) has observed a normal content of glycogen per 106 leukocytes in chronic myelocytic leukemia. In this laboratory, recent studies (6) have shown that whereas total leukocyte glycogen is frequently within the normal range, unit myeloid cell leukocyte glycogen is low. This is not explainable solely in terms of cell immaturity in the leukemic blood analyzed. In polycythemia vera of the type associated with leukocytosis and leukemoid reactions, the unit myeloid cell glycogen is substantially above normal (6) . Wagner (4) has observed increased leukocyte glycogen values in polycythemia vera and Wachstein (5) has made similar qualitative observations on the basis of histochemical staining techniques. The leukocyte glycogen con-tent may be remarkably increased in Von Gierke's disease (1, 7) .
It is the object of this study to present further observations on the glycogen content of human leukocytes in health and in various disease states employing an adaptation of the anthrone technique (8, 9) to glycogen measurements in white blood cells.
METHODS
Since the myeloid leukocytes are apparently the only significant source of blood glycogen (1) the following method has been employed in the estimation of leukocyte glycogen. Blood was collected as for the phosphatase determination (10) in a freshly prepared saline solution of bovine fibrinogen (Fraction I), Armour, and the erythrocytes allowed to settle. Since cally treated and the standard was prepared by adding 4 ml. of distilled water containing 50 micrograms of glucose to the second blank material. The color developed was read after 10 minutes at wave length 620 using the Beckman Model B spectrophotometer. The determination was related to the glucose standard and the glycogen content of the unknowns computed by the standard formula:
micrograms of glycogen in aliquot = 15. >v V-optical density of unknown, S-optical density of 50 microgram glucose standard, 1.11-factor of conversion of glucose to glycogen.
To our knowledge the anthrone method (9) has not previously been employed specifically for leukocyte glycogen. It has the advantage that hydrolysis of the purified glycogen is not necessary. The anthrone reagent must be prepared fresh, the sulphuric acid of high purity, and care must be taken to prevent contamination with lint or other material which will react with this reagent.
RESULTS
Normal subjects. Neutrophilic leukocytosis of infection. Twentyeight determinations of leukocyte glycogen content were made in 24 subjects with neutrophilic leukocytosis of infection. In two determinations recorded, the leukocyte count was within the normal range but one day previously had been elevated on the basis of an infectious process. The subjects studied had pneumonia, tonsillitis, meningitis, urinary tract infection, surgical complications, acute appendicitis, tuberculous pericarditis, and bacteremia of various types as a cause of leukocytosis. The mean glycogen content per 1010 myeloid leukocytes was 86.7 mg., substantially above the mean for normal subjects. Comparison with other disease states and with normal subjects is indicated in Figure 1 . Twenty-one of twentyeight determinations were above the normal mean but only two above the highest normal value obtained. However, almost 40 per cent of the values were above 90 mg. while only 14 per cent of values in normal subjects were in this range. It may be concluded that the glycogen content of myeloid leukocytes is appreciably elevated on the average in presence of neutrophilic leukocytosis of infection. These elevated leukocyte counts and high unit cell glycogen values, of course, are reflected in marked elevations in total circulating leukocyte glycogen.
Determinations were also made in eight cases with neutrophilic leukocytosis associated with such non-infectious processes as decompensated liver disease and metastatic carcinoma. All values per 1010 myeloid leukocytes were within the normal range and only one above 88 mg. This subject had metastatic carcinoma and marked leukocytosis ranging from 60,000 to 78,000 per cu. mm. On successive determinations unit cell glycogen was well above that of the highest normal subject, being over 130 mg. per 1010 myeloid leukocytes. In this subject the leukocyte glycogen content per 100 ml. of blood was as high as 102 mg., more than 14 times the highest value obtained in any normal subject.
Chronic myelocytic leukemia, polycythemia vera with leukocytosis and/or leukemoid reactions, and other "myeloproliferative syndromes." The data obtained on leukocyte glycogen in these conditions has been incorporated in a separate study (6) reported elsewhere and will only be summarized here. In chronic myelocytic leukemia, while the glycogen content per 1010 leukocytes of all types is usually within the normal range, the more significant value per 1010 myeloid leukocytes was consistently low in 14 subjects with this disease. The mean value was 37.9 mg., approximately one-half that of normal subjects. In sharp contrast, myeloid leukocyte glycogen in polycythemia vera of the type associated with marked leukocytosis and leukocyte immaturity was higher than in any other disease state studied. The mean content per 1010 myeloid leukocytes was 116.2 mg. in 15 subjects. The differences are not explainable in terms of therapy or the differential leukocyte picture and must be considered as evidence of a marked metabolic difference in the two conditions. This is true even in cases which clinically may be suspected of having undergone so-called leukemic transition. In other "myeloproliferative syndromes" (11) thought not to be either polycythemia vera or chronic myelocytic leukemia, but with similar leukocyte pictures, the pattern of glycogen content has not been consistent. Some have exhibited high glycogen content of myeloid leukocytes; others have shown low or normal values.
These findings have been discussed previously in more detail (6) . For purposes of comparison, the values in chronic myelocytic leukemia and in polycythemia vera are incorporated in Figure 1 (6, 10, 13) have indicated a certain parallelism between glycogen content and alkaline phosphatase activity of leukocytes. In conditions where blast cells or lymphocytes are the predominating cell type, both glycogen content and alkaline phosphatase activity of leukocytes are low. In chronic myelocytic leukemia a similar situation exists whereas in polycythemia vera with leukocytosis and/or leukemoid features, both values tend to be well above the normal range. The parallelism is not absolute, however. On the average, the highest unit cell leukocyte alkaline phosphatase values are found in the neutrophilic leukocytoses of infection. Glycogen content is also elevated above normal in this situation, but not quite so strikingly as in polycythemia vera with leukocyte abnormalities where the highest values are observed. In this connection, it should be mentioned that in polycythemia without concomitant leukocyte abnormalities, both unit leukocyte alkaline phosphatase and glycogen are usually normal. Whether this parallelism between glycogen content and alkaline phosphatase activity is fortuitous or represents a metabolic interrelationship cannot be stated with certainty.
SUMMARY
Data are presented on the glycogen content of separated human leukocytes in health and in various disease states.
Leukocyte glycogen has been observed to remain relatively unchanged during the postprandial rise in blood sugar, in poorly controlled diabetes mellitus and in the presence of massive cortisone therapy.
Unit cell myeloid leukocyte glycogen tends to be substantially low in chronic myelocytic leukemia and high in polycythemia vera with leukocytosis and/or leukemoid features. It also tends to be substantially above normal in the neutrophilic leukocytoses of infection.
The data confirm previous observations that lymphocytes and blast cells are either glycogenfree or extremely poor in glycogen content.
The parallelism between unit leukocyte glycogen and alkaline phosphatase activity is discussed.
